Maja Tarailo-Graovac

Dr. Maja Tarailo-Graovac

PhD (Doctor of Philosophy)

Positions

Associate Professor

Cumming School of Medicine, Department of Biochemistry and Molecular Biology

Child Health & Wellness Researcher

Alberta Children's Hospital Research Institute

Lead, Precision Health Program (Graduate Certi/Dipl/MSc)

Cumming School of Medicine

Contact information

Email

Web presence

Phone number

Office: 403.210.9395

Preferred method of communication

Administrative Assistant

Suporna Banik
Email: suporna.banik@ucalgary.ca
Office: 403.210.9728

Background

Educational Background

B.S. , University of British Columbia, 2002

Doctor of Philosophy , University of British Columbia, 2008

Research

Areas of Research

Genetic Disorders, Model Organism, Rare diseases

 

My research program uses multidisciplinary approach (human and model organism genomics; ‘wet’ and ‘dry’ lab approaches) to understand the genomics of rare human disorders. As I continue to work on improving the diagnostic potential of genome-wide sequencing (e.g. detection of ‘all’ classes of genetic variation in a single test and discovery of novel gene-disease associations), I seek to understand genetic contributors to phenotypic variability in rare disorders. Namely, my research combines an elegance of Caenorhabditis elegans’ genetics/genomics with human genomics to understand why two individuals with the same rare disease-causing variant may have different clinical presentation of the disease (severe-mild-none)? In other words, I am asking whether other variants in a genome exist that may alleviate or exacerbate the severity of the disease-causing variant. Identification of such genetic modifiers provides important information about biological networks of human disease genes, and ability to accurately interpret variant pathogenicity in context of an individual genome, not unlike personalized medicine. This in turn allows for better disease prognosis, prevention and patient management. Furthermore, knowledge of genetic modifiers (suppressors in particular) may reveal natural health protectors and hence therapeutic targets, an urgent need for rare disorders (>95% do not have a single FDA approved drug).

Participation in university strategic initiatives

Courses

Course number Course title Semester
MDGE 725 Applied Genomics Winter
MDPR 600 Foundations of Precision Health Fall
MDPR 610 Omics Applications Winter

Awards

  • CSMB New Investigator, Canadian Society for Molecular Biosciences. 2024
  • Jonathan Lytton Associate Professor Award, University of Calgary. 2023
  • Outstanding Reviewer, Canadian Institutes of Health Research. 2020
  • 2020 #GREAT Supervisor, University of Calgary. 2020
  • Leon Browder Rising Star Award, University of Calgary. 2019

Publications